Assays that detect hepatitis C, hepatitis C genotyping, and human immunodeficiency virus are now commercially available in countries accepting the CE mark.
An updated software package from Definiens seeks to detect regions of interest accurately and distinguish cell types and cell subtypes within target regions across any number of tissue slides.
This month’s issue features middleware systems from such companies as Alere, Clinical Software Solutions, Siemens Healthcare, and Sysmex America.
This month's issue features laboratory information systems and laboratory information management systems from such companies as Apex Healthware, Genologics, McKesson, and Orchard Software Corp.
Cologuard is designed to be patient- and physician-friendly, and is highly automated to support efficiencies in Exact Sciences' lab.
Exact Sciences overcame significant obstacles to bring cancer screening innovation to patients.
After weeks of alerts from public health authorities, the World Health Organization recently acknowledged that the Zika virus is “spreading explosively” in the Western Hemisphere.
The DiscoveryMap platform from Myriad RBM has identified combinations of 15 protein biomarkers associated with cardiovascular events in patients with diabetes.
Idex Health & Science has launched a newly expanded portfolio of fluidic, microfluidic, and optical components and capabilities.
Four transplant centers are participating in an early access program for the company’s blood test for kidney transplant recipients.
The caps are suitable for biobanks and other laboratory facilities requiring long-term sample storage at low temperatures.
A special latching feature enables the valve to remain in open or closed positions over indefinite periods of time without consuming battery power.
The allergen component tests by Thermo Fisher Scientific detect immunoglobulin E sensitization to hazelnut, walnut, and cashew nut proteins.
Under a nonexclusive agreement, Henry Schein will market Cepheid’s GeneXpert system to its non-acute care laboratory customers in the United States.
In partnership with biopharmaceutical companies, Leica Biosystems and Advanced Cell Diagnostics are collaborating to develop and commercialize fully automated RNAscope-based companion diagnostics.
With the acquisition, Abbott gains leadership in the $5.5 billion point-of-care segment, broadens its diagnostics footprint, and enhances access to fast-growing diagnostics channels.
This month's Product Spotlight features equipment, consumables, and labware from companies such as EKF Diagnostics, Olympus, Platinum Code, and Randox Laboratories.
This month's Product News includes focused gene expression panels, a cystatin C assay, a supply and procedure cart system, and a modular embedding system.
The company recently received ethical approval to commence a 6-month clinical study using its urine test for cancer.
Named Grail, the business seeks to enable early cancer detection via blood-based screening.